A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
Authors
Keywords
T cells, Cytotoxic T cells, HIV-1, Immune response, Highly-active antiretroviral therapy, T helper cells, Vaccination and immunization, Vaccines
Journal
PLoS One
Volume 10, Issue 11, Pages e0141456
Publisher
Public Library of Science (PLoS)
Online
2015-11-07
DOI
10.1371/journal.pone.0141456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential Implication of Residual Viremia in Patients on Effective Antiretroviral Therapy
- (2015) Gautam K. Sahu AIDS RESEARCH AND HUMAN RETROVIRUSES
- Understanding HIV Latency: The Road to an HIV Cure
- (2015) Matthew S. Dahabieh et al. Annual Review of Medicine
- HIV Eradication: Combinatorial Approaches to Activate Latent Viruses
- (2014) Elisa De Crignis et al. Viruses-Basel
- Therapeutic and prophylactic DNA vaccines for HIV-1
- (2013) Lorenzo Antonio Ramirez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical applications of attenuated MVA poxvirus strain
- (2013) Carmen Elena Gómez et al. Expert Review of Vaccines
- Immune interventions in HIV infection
- (2013) Guislaine Carcelain et al. IMMUNOLOGICAL REVIEWS
- Harnessing CD4+ T cell responses in HIV vaccine development
- (2013) Hendrik Streeck et al. NATURE MEDICINE
- Vaccine and immunotherapeutic interventions
- (2013) Giuseppe Pantaleo et al. Current Opinion in HIV and AIDS
- Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
- (2013) Thomas Rasmussen et al. Human Vaccines & Immunotherapeutics
- NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients
- (2012) Alexandre Harari et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?
- (2012) Guido Vanham et al. Retrovirology
- Vector replication and expression of HIV-1 antigens by the HIV/AIDS vaccine candidate MVA-B is not affected by HIV-1 protease inhibitors
- (2012) Juan García-Arriaza et al. VIRUS RESEARCH
- Therapeutic vaccines against HIV infection
- (2012) Felipe García et al. Human Vaccines & Immunotherapeutics
- SPICE: Exploration and analysis of post-cytometric complex multivariate datasets
- (2011) Mario Roederer et al. CYTOMETRY PART A
- The successes and failures of HIV drug discovery
- (2011) Chie Hashimoto et al. Expert Opinion on Drug Discovery
- The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens
- (2011) C. E. Gomez et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
- (2011) Felipe García et al. VACCINE
- MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays
- (2010) S Kutscher et al. GENE THERAPY
- Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
- (2010) José Luis Nájera et al. PLoS One
- Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
- (2010) Juan García-Arriaza et al. PLoS One
- Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects
- (2010) Sarah Howles et al. VACCINE
- Heterologous prime–boost vaccination
- (2009) Shan Lu CURRENT OPINION IN IMMUNOLOGY
- The Spanish HIV BioBank: a model of cooperative HIV research
- (2009) Isabel Garcia-Merino et al. Retrovirology
- Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
- (2008) Thomas C. Greenough et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started